Related Experiment Video

Updated: Feb 14, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K

Advances in studies of tyrosine kinase inhibitors and their acquired resistance

Qinlian Jiao1, Lei Bi2, Yidan Ren1

  • 1International Biotechnology R&D Center, Shandong University School of Ocean, 180 Wenhua Xi Road, Weihai, Shandong, 264209, China.

Molecular Cancer
|February 20, 2018
PubMed

Insights

Protein tyrosine kinases (PTKs) are crucial in cell signaling and cancer. Tyrosine kinase inhibitors (TKIs) show promise in cancer treatment but acquired resistance remains a challenge.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein tyrosine kinases (PTKs) are key enzymes in cellular signal transduction, regulating critical processes like cell growth and differentiation.
  • Dysregulated PTK expression is implicated in various cancers, contributing to tumor invasion, metastasis, and angiogenesis.
  • PTKs are established targets for anti-cancer drug development.

Purpose of the Study:

  • To review the role of PTKs in cancer development.
  • To outline the mechanisms of action for tyrosine kinase inhibitors (TKIs) in cancer therapy.
  • To summarize acquired resistance mechanisms against TKIs.

Main Methods:

  • Literature review of PTK function in cancer.
  • Analysis of TKI therapeutic pathways.
  • Examination of molecular mechanisms underlying TKI resistance.

Main Results:

  • PTKs play a significant role in cancer cell proliferation and progression.
  • TKIs effectively inhibit cancer cell growth by targeting PTK activity.
  • Acquired resistance to TKIs is a major clinical limitation.

Conclusions:

  • Understanding PTK signaling is vital for cancer therapy.
  • TKIs represent a significant advancement in cancer treatment.
  • Further research into TKI resistance mechanisms is necessary to improve patient outcomes.
Keywords:
Acquired resistanceCancerProtein tyrosine kinaseTyrosine kinase inhibitors

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.3K

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.0K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
561
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K